Aurora Cannabis Inc (ACB) Stock Price Today
Medical imaging workstations market to double by 2036, driven by AI and cloud tech growth
The global medical imaging workstations market is projected to grow from USD 6.20 billion in 2026 to USD 12.55 billion by 2036, at a CAGR of 7.3%. Growth is fueled by rising chronic disease prevalence, increased diagnostic imaging demand, and advance...
Global sacral neuromodulation market to grow at 11.1% CAGR, reaching $3.92B by 2036 driven by tech advances and aging population
The global sacral neuromodulation market is projected to grow from $1.37 billion in 2026 to $3.92 billion by 2036, at an 11.1% CAGR. Growth is fueled by rising cases of urinary and fecal incontinence, demand for minimally invasive treatments, and an ...
Mexico's animal healthcare market to grow to $3.34B by 2031, driven by pets, livestock, and diagnostics.
The Mexico animal healthcare market is projected to grow from $2.13 billion in 2025 to $3.34 billion by 2031, at a CAGR of 7.84%. Growth is fueled by rising spending on companion animals, expanding livestock production, and innovations in veterinary ...
Kendal Nutricare faces government referral for ignoring advertising compliance inquiry.
Kendal Nutricare Limited will be referred to government and state agencies after refusing to participate in a compliance inquiry by the BBB National Programs’ National Advertising Division. The inquiry followed a challenge by Abbott Laboratories rega...
IMUNON's IMNN-001 boosts anti-tumor T-cell activity, improving survival in advanced ovarian cancer Phase 2 trial.
IMUNON, Inc. presented new data from its Phase 2 OVATION 2 trial showing that IMNN-001, combined with chemotherapy, significantly enhances anti-tumor T-cell immune responses in advanced ovarian cancer patients. This immune activation correlates with ...
Ozempic market to hit $113.95B by 2032 with 24.9% CAGR driven by rising diabetes and metabolic health demand.
The Ozempic market, valued at $30.04 billion in 2026, is projected to grow to $113.95 billion by 2032, with a CAGR of 24.89%. This growth is fueled by increasing demand for diabetes and metabolic health treatments, wider adoption of GLP-1 therapies, ...
Canary Capital launches first U.S. spot staked INJ ETF on Nasdaq, offering exposure plus staking rewards.
Canary Capital has launched the Canary Staked INJ ETF (INJC) on Nasdaq, providing investors exposure to INJ, the native token of the Injective blockchain. The ETF not only tracks INJ's price but also earns staking rewards from the network's proof-of-...
Nexans to supply 420 km cable for Greece's major 1 GW Corinth-Kos power link
Nexans has signed a subcontract to deliver a 420 km mass-impregnated 110 kV cable system for the 1 GW, 320 kV Corinth-Kos HVDC interconnection in Greece. This project, awarded to Hellenic Cables and partners, will connect the Dodecanese islands to ma...
HCW Biologics' novel cancer drug HCW11-040 recognized for innovation at SITC 2026 meeting
HCW Biologics announced that its new cancer immunotherapy drug, HCW11-040, was selected as one of the Top 150 abstracts at the 41st Annual Meeting of the Society for Immunotherapy of Cancer (SITC). HCW11-040 is a first-in-class fusion immunotherapeut...
Coherent's margins improve amid InP capacity limits; $20bn PhotonLink deal highlights scarcity sales.
Coherent Corp. shares a key indium phosphide (InP) capacity constraint with Lumentum but differs by selling modules at market prices rather than scarcity, focusing on volume and inventory management. Margins are improving faster than expected, suppor...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.